Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -168.97% is 61% above its 1-year average of -428.47%, around the middle of its 1-year range (-597.22%–40.05%).
60.56% above its 12-month average of -428.47%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2020 (2020-03-31): 40.05%.
EBITDA MARGIN
-168.97%
EBITDA MARGIN AVG TTM
-428.47%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+60.56%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$19.77M
EBITDA Margin
-13586.02%
TTM Avg
-13586.02%
3Y Avg
-13586.02%
5Y Avg
-13586.02%
Market Cap
$22.00M
EBITDA Margin
-7.62%
TTM Avg
-5.66%
3Y Avg
-2.78%
5Y Avg
-31.67%
Market Cap
$18.65M
EBITDA Margin
-779.07%
TTM Avg
-389.93%
3Y Avg
-389.93%
5Y Avg
-2320.55%
Market Cap
$18.41M
EBITDA Margin
-12.76%
TTM Avg
-13.93%
3Y Avg
-43.67%
5Y Avg
-34.75%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $20.53M | -168.97% | -428.47% | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.77M | -13586.02% | -13586.02% | -13586.02% | -13586.02% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.42M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | -7.62% | -5.66% | -2.78% | -31.67% |
| Modular Medical, Inc. (MODD)vs › | $22.25M | N/A | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | -779.07% | -389.93% | -389.93% | -2320.55% |
| P3 Health Partners Inc. (PIII)vs › | $18.41M | -12.76% | -13.93% | -43.67% | -34.75% |
| LeonaBio, Inc. (LONA)vs › | $22.68M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | N/A | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
-169.0%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2020-03-31 | 40.05% |
| 2019-12-31 | -561.35% |
| 2019-09-30 | -563.11% |
| 2019-06-30 | -597.22% |
| 2019-03-31 | -460.72% |
